IP Library Granted Patent US 7,973,142
Granted Patent B2
US 7,973,142 · App. 11/784,094 · Granted Jul 5, 2011

Antibodies that bind human protein tyrosine phosphatase beta (HPTPβ)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,973,142
App. No.
11/784,094
Granted
Jul 5, 2011
Kind
B2
Abstract

Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (HPTPβ), and uses thereof.

Claims (26)

1. An isolated antibody or antigen-binding fragment thereof which binds to human protein tyrosine phosphatase beta (HPTPβ), wherein said antibody or antigen-binding fragment thereof regulates angiogenesis.

2. The antibody or antigen-binding fragment thereof according to claim 1 , wherein the antibody or antigen-binding fragment thereof binds the N-terminal portion of HPTPβ.

3. The antibody or antigen-binding fragment thereof according to claim 2 , wherein the antibody or antigen-binding fragment thereof binds the first FN3 repeat of HPTPβ.

4. The antibody or antigen-binding fragment thereof according to claim 3 , wherein the first FN3 repeat of HPTPβ has the sequence as shown in SEQ ID NO:11.

5. The antibody or antigen-binding fragment thereof according to claim 1 , wherein the antibody is a monoclonal antibody or antigen-binding fragment thereof.

6. The monoclonal antibody according to claim 5 produced by hybridoma cell line ATCC No. PTA-7580 or the antigen-binding fragment of the monoclonal antibody according to claim 5 produced by hydriboma cell line ATCC No. PTA-7580.

7. The antibody or antigen binding fragment thereof according to claim 1 , wherein the antibody or antigen binding fragment thereof is humanized.

8. The antibody or antigen-binding fragment thereof according to claim 6 , which comprises antigen binding region residues from the monoclonal antibody R15E6, ATCC No. PTA-7580, and is humanized.

9. The antigen binding fragment according to claim 7 , wherein the fragment comprises heavy and light chain variable regions.

10. An antigen binding fragment according to claim 7 , wherein the antigen-binding fragment is selected from the group consisting of an Fv fragment, and Fab fragment, an Fab' fragment, and an F(ab') 2 fragment.

11. The monoclonal antibody R15E6, produced by hybridoma cell line ATCC No. PTA-7580 which binds to human protein tyrosine phosphatase beta (HPTPβ).

12. A pharmaceutical composition, comprising:

a. the antibody or antigen-binding fragment thereof according to claim 1 , and

b. a pharmaceutically acceptable carrier.

13. A pharmaceutical composition, comprising:

a. the antibody or antigen-binding fragment thereof according to claim 6 , and

b. a pharmaceutically acceptable carrier.

14. A pharmaceutical composition, comprising:

a. the antibody or antigen-binding fragment thereof according to claim 7 , and

b. a pharmaceutically acceptable carrier.

15. A pharmaceutical composition, comprising:

a. the antibody or antigen-binding fragment thereof according to claim 8 , and

b. a pharmaceutically acceptable carrier.

16. A pharmaceutical composition, comprising:

a. the antibody according to claim 11 or a fragment thereof; and

b. a pharmaceutically acceptable carrier.

Assignments (12)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2021
From: AERPIO PHARMACEUTICALS, INC.
To: EYEPOINT PHARMACEUTICALS, INC.
Reel/Frame 057448/0033 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2020
From: AERPIO THERAPEUTICS LLC
To: AERPIO PHARMACEUTICALS, INC.
Reel/Frame 052432/0789 →
CHANGE OF NAME Recorded Jul 31, 2019
From: AERPIO THERAPEUTICS, INC.
To: AERPIO THERAPEUTICS LLC
Reel/Frame 049920/0076 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2013
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 031531/0538 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2012
From: AKEBIA THERAPEUTICS, INC.
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 027795/0844 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2011
From: WARNER CHILCOTT COMPANY, LLC
To: AKEBIA THERAPEUTICS INC.
Reel/Frame 027445/0100 →
PATENT RELEASE Recorded Dec 23, 2011
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 027443/0164 →
SECURITY AGREEMENT Recorded Mar 30, 2011
From: WARNER CHILCOTT COMPANY LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026064/0607 →
RELEASE - REEL 023456, FRAME 0052 Recorded Mar 29, 2011
From: CREDIT SUISSSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
To: WARNER CHILCOTT COMPANY LLC
Reel/Frame 026042/0046 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2010
From: PROCTER & GAMBLE COMPANY, THE
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 023796/0417 →
SECURITY AGREEMENT Recorded Nov 2, 2009
From: WARNER CHILCOTT COMPANY, LLC
To: CREDIT SUISSE, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 023456/0052 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2007
From: PETERS, KEVIN GENE; ROTELLO, ROCCO JAMIE; DAVIS, MICHAEL GLEN
To: PROCTER & GAMBLE COMPANY, THE
Reel/Frame 019740/0548 →